Yahoo
Canadian Sec - Delayed Quote CAD

Sona Nanotech Inc. (SONA.CN)

0.2800 0.0000 (0.00%)
At close: October 30 at 1:03:58 PM EDT
Chart Range Bar
Loading chart for SONA.CN
  • Previous Close 0.2800
  • Open 0.2850
  • Bid 0.2650 x --
  • Ask 0.2850 x --
  • Day's Range 0.2800 - 0.2850
  • 52 Week Range 0.2600 - 0.6500
  • Volume 26,130
  • Avg. Volume 50,423
  • Market Cap (intraday) 34.384M
  • Beta (5Y Monthly) 1.02
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests. The company was founded in 2013 and is based in Halifax, Canada.

www.sonanano.com

--

Full Time Employees

October 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

SONA.CN
34.88%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

SONA.CN
55.56%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

SONA.CN
55.56%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

SONA.CN
15.15%
S&P/TSX Composite index (^GSPTSE)
69.32%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY25
Revenue --
Earnings -646.88k
Profit Margin 0.00%

Q2

FY25

Q3

FY25

-600K
-400K
-200K
0
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -138.08%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -2.44M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.21k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    41.75k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: